The Lancet Voice
by The Lancet Group
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 15 chart positions in 15 markets.
By chart position
- 🇦🇺AU · Medicine#7930K to 100K
- 🇲🇽MX · Medicine#3930K to 100K
- 🇮🇹IT · Medicine#8910K to 30K
- 🇰🇷KR · Medicine#1351K to 10K
- 🇮🇳IN · Medicine#1401K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
61K to 213K🎙 Weekly cadence·160 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
122K to 425K🇦🇺24%🇲🇽24%🇻🇳24%+12 more - Active Followers
Loyal subscribers who consistently listen
36K to 128K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Recent guests
Recent episodes
What is "AI psychosis"?
Aug 7, 2026
23m 03s
Can we eliminate viral hepatitis?
Jul 27, 2026
24m 56s
How will the AI change the NHS?
Jul 17, 2026
17m 12s
What's happening in Latin America?
Jul 10, 2026
36m 00s
Research integrity in the age of AI
Jun 26, 2026
25m 08s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 8/7/26 |  What is "AI psychosis"? | What's the truth behind media reports of people experiencing "AI psychosis" after interacting with chatbots? Editors Niall Boyce and Miriam Sabin are joined by psychiatrist Matthew Nour of Oxford University and Microsoft AI to separate fact from fiction, and understand more about the ways in which artificial intelligence might affect human mental health. The Lancet Voice is part of the Lancet Group podcast offering. Editorial team: Niall Boyce, Miriam Sabin, Jessamy Bagenal, Richard Horton, and Gavin Cleaver Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at thelancet.comFollow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv | 23m 03s | ||||||
| 7/27/26 | Can we eliminate viral hepatitis? | 287 million people live with viral hepatitis worldwide. But vaccination and treatment offer new hope that elimination is possible. Lancet editor Niall Boyce discusses progress and challenges with Dr John Ward, Director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health. Visit https://www.taskforce.org/viral-hepatitis/ and https://www.worldhepatitisday.org/ to find out more. The Lancet Voice is part of the Lancet Group podcast offering. Editorial team: Niall Boyce, Miriam Sabin, Jessamy Bagenal, Richard Horton, and Gavin Cleaver Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at thelancet.comFollow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv | 24m 56s | ||||||
| 7/17/26 | AI in healthcareNHS triage+3 | Chloe Wilson | The LancetNHS | — | AINHS+5 | — | 17m 12s | ||
| 7/10/26 | health assessmentLatin America+5 | Taissa VillaMarcia de Castro | The Lancet Regional Health AmericasHarvard University+3 | Latin AmericaVenezuela+2 | Latin Americahealth system+8 | — | 36m 00s | ||
| 6/26/26 | research integrityAI in science+3 | Lex BouterMai Har Sham | Vrije Universiteit AmsterdamChinese University of Hong Kong+1 | — | research integrityAI+3 | — | 25m 08s | ||
| 6/17/26 | social mediayouth health+3 | Esther Lau | The Lancet Child and Adolescent HealthThe Lancet Group | UK | UK governmentsocial media ban+5 | — | 16m 27s | ||
| 6/2/26 | bioethicshealth care+3 | Ezekiel Emanuel | The Lancet GroupThe Lancet Voice | — | bioethicshealth care providers+3 | — | 36m 14s | ||
| 5/1/26 | public healthmedical history+3 | Dr Yvonne Ho | — | Manchuria | Dr Wu Lien-Tehpublic health+7 | — | 33m 58s | ||
| 4/17/26 | cannabis legalizationhealth effects+3 | Professor Deborah Hasin | Columbia UniversityThe Lancet Group | — | cannabislegalization+5 | — | 33m 24s | ||
| 3/9/26 | global healthfunding cuts+3 | RichardJessamy | The LancetThe Lancet Global Health+2 | — | global healthIndia+3 | — | 52m 55s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/24/26 | clinical trialsSPIRIT guidelines+3 | Ami BabaMartin Offringa | The Lancet Child & Adolescent HealthBMJ+1 | — | clinical trialsSPIRIT+5 | — | 25m 05s | ||
| 1/15/26 | sustainable healthcareCOP30+3 | Iris Blom | London School of Hygiene & Tropical MedicineThe Lancet Commission on Sustainable Healthcare | Brazil Amazon | COP30sustainable healthcare+4 | — | 22m 45s | ||
| 1/2/26 | NHS workforcetraining issues+3 | Mumtaz Patel | RCP | — | NHSworkforce+5 | — | 42m 50s | ||
| 10/30/25 | vaccinesCOVID-19+4 | Dr. Seth Berkley | Gavi, the Vaccine AllianceCOVAX+1 | — | vaccinesCOVID-19+6 | — | 31m 31s | ||
| 10/16/25 | Alzheimer's diseaseliver cancer+4 | RichardJessamy | LancetLancet Group+2 | — | Alzheimer'sliver cancer+5 | — | 39m 38s | ||
| 10/2/25 | healthy food systemssustainability+4 | Walter WillettShakuntala Thilsted+1 | EAT-Lancet CommissionLancet+1 | — | EAT-Lancetfood systems+5 | — | 40m 19s | ||
| 9/19/25 | Making scientific research work for women | Scientific research has traditionally treated the male body as the default, resulting in health inequity and poor outcomes for women in a world not designed for them. The Sex and Gender Equity in Research (SAGER) guidelines are an attempt to make sure research is designed for everyone, and that the outcomes better serve everyone. Editor-in-chief of The Lancet Haematology Lan-Lan Smith and editor-in-chief of The Lancet Regional Health Americas Taissa Vila join Gavin to discuss how the history ... | 27m 04s | ||||||
| 8/28/25 | ”Doctored”, plastics, and NCDs | Gavin, Richard, and Jessamy enter the studio once more for a Lancet Voice chat. A new book on Alzheimer's disease causes controversy across the Lancet team, we discuss the new Countdown on Plastics & Health, and a quick look at the problems facing the upcoming UN High Level Meeting on NCDs. You can read the Lancet Countdown on health and plastics here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01447-3/fulltext?dgcid=buzzsprout_tlv_podcast_August_25_lancet Send us ... | 44m 04s | ||||||
| 8/14/25 | Step counts and health outcomes - 7,000 or 10,000? | Where did the 10,000 steps recommendation come from? Why has it proven so stubborn? What's the science behind the new recommendations? How strong is the evidence? Professor Melody Ding joins Gavin to talk about her new systematic review published in The Lancet Public Health, examining the relationship between step counts and health outcomes. We also explore the challenges of measuring physical activity, the importance of inclusive research, and the role of environmental and policy interventio... | 27m 24s | ||||||
| 7/31/25 | The next generation of weight-loss drugs | It’s no exaggeration to say that the past decade has revolutionized how we think about and treat obesity. Drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) have dominated headlines, enabling significant weight loss at speeds once considered unthinkable. The market for innovative weight loss medications is booming, with pharmaceutical companies investing heavily in hopes of developing the next blockbuster drug. However, amid this race for market dominance, many experts are questioning... | 38m 11s | ||||||
| 7/17/25 | One Health | The sustainability of our existence relies on the health of every human, every animal, and the environment we all share. Published today, "The Lancet One Health Commission: harnessing our interconnectedness for equitable, sustainable, and healthy socioecological systems" highlights challenges like climate change, food security, and antimicrobial resistance to lay out the One Health approach to informing and implementing solutions. Senior Executive Editor at The Lancet Pam Das is joined by lea... | 43m 08s | ||||||
| 7/3/25 | Proof, truth, and infectious disease | Professor Adam Kucharski joins Gavin & Jessamy to discuss the intersection of mathematics, epidemiology, and truth, off the back of his new book, Proof. How do we generate scientific knowledge? How can we communicate uncertainty? What is the impact of social media and artificial intelligence on public trust in science? Adam also tells us about the importance of public engagement, the nuances of misinformation, the importance of transparency in policy, the future of scientific communicatio... | 38m 23s | ||||||
| 6/19/25 | Femtech and women’s health | How safe is it to use period tracking and digital contraception apps? Who is your data being shared with? What regulation actually exists in this area to protect app users? Femtech offers women digital tools for tracking reproductive health. Gavin and Jessamy are joined by Dr. Catriona McMillan, Senior Research Fellow in Medical Law and Ethics at the University of Edinburgh, to talk about how accurate these apps actually are, significant concerns about data privacy, and what regulatory oversi... | 25m 00s | ||||||
| 6/5/25 | The World Health Assembly, adolescent health, and the pace of innovation | Richard, Jessamy, and Gavin reflect on developments at the 78th World Health Assembly, including the passage of the pandemic agreement and shifting dynamics in global health leadership. What's next for WHO without US engagement? How has WHA changed over the years? We also address the importance of recommitting to adolescent health following our new Commission, and discuss a controversial recent study about the pace of scientific innovation. You can read the second Lancet Commission on Adolesc... | 44m 20s | ||||||
| 5/22/25 | Human flourishing and research funding | Gavin, Richard, and Jessamy return to the studio to discuss some publications that caught their eye this month, and in doing so set themselves the lofty goal of examining how meaning, purpose, optimism, and social context shape our understanding of health beyond traditional clinical measures. We also ponder the future of research and higher education in the face of funding challenges in both the US and the UK. Articles mentioned in this episode: The Global Flourishing Study: https://www.natur... | 38m 19s | ||||||
Showing 25 of 169
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for The Lancet Voice
Peaked at #14 in VN, currently #14 in VN.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| VN | — | #14 | #14 | — |
| HU | — | #23 | #23 | — |
| Mexico | — | #39 | #39 | — |
| TH | — | #74 | #74 | — |
| Australia | — | #79 | #79 | — |
| Italy | — | #89 | #89 | — |
| CZ | — | #98 | #98 | — |
| SA | — | #115 | #115 | — |
| South Korea | — | #135 | #135 | — |
| India | — | #140 | #140 | — |
| VN | — | #144 | #144 | — |
| Japan | — | #155 | #155 | — |
| BE | — | #160 | #160 | — |
| NG | — | #160 | #160 | — |
| HK | — | #184 | #184 | — |
| PH | — | #197 | #197 | — |
Chart Positions
16 placements across 15 markets.
Chart Positions
16 placements across 15 markets.